LFST

LifeStance Health Group, Inc. Healthcare - Medical Care Facilities Investor Relations →

YES
2.9% BELOW
↑ Moving away Was -4.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $6.59
14-Week RSI 41
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.25

LifeStance Health Group, Inc. (LFST) closed at $6.40 as of 2026-03-20, trading 2.9% below its 200-week moving average of $6.59. This places LFST in the below line zone. The stock moved further from the line this week, up from -4.1% last week. The 14-week RSI sits at 41, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.25 ratio) is neutral — neither side is clearly dominating.

Over the past 201 weeks of data, LFST has crossed below its 200-week moving average 2 times. On average, these episodes lasted 94 weeks. Historically, investors who bought LFST at the start of these episodes saw an average one-year return of +11.6%.

With a market cap of $2.4 billion, LFST is a mid-cap stock. The company generates a free cash flow yield of 4.6%. Return on equity stands at 0.7%. The stock trades at 1.6x book value.

Share count has increased 3.3% over three years, indicating dilution.

Over the past 3.9 years, a hypothetical investment of $100 in LFST would have grown to $85, compared to $166 for the S&P 500. LFST has returned -3.9% annualized vs 13.8% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: LFST vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After LFST Crosses Below the Line?

Across 1 historical episodes, buying LFST when it crossed below its 200-week moving average produced an average return of +13.0% after 12 months (median +13.0%), compared to +3.0% for the S&P 500 over the same periods. 100% of those episodes were profitable after one year. After 24 months, the average return was -26.0% vs +32.0% for the index.

Each line shows $100 invested at the moment LFST crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

LFST has crossed below its 200-week MA 2 times with an average 1-year return of +11.6% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
May 2022Dec 202518658.6%+11.6%-14.6%
Mar 2026Ongoing2+4.1%Ongoing+1.1%
Average94+11.6%

Frequently Asked Questions

Is LFST below its 200-week moving average?

Yes. As of 2026-03-20, LifeStance Health Group, Inc. (LFST) is trading 2.9% below its 200-week moving average of $6.59. The current price is $6.40.

What is LFST's 200-week moving average price?

LifeStance Health Group, Inc.'s 200-week moving average is $6.59 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when LFST drops below its 200-week moving average?

LFST has crossed below its 200-week moving average 2 times in our data. On average, buying at that moment produced a one-year return of +11.6%. These dips have historically been decent entry points. These episodes lasted 94 weeks on average.

Is LFST a good value right now?

Here's what our data says about LFST as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 41. Free cash flow yield is 4.6%. Return on equity is 0.7%. Price-to-book is 1.6x. This is not a buy or sell recommendation — always do your own research.

How does LFST compare to the S&P 500?

Over the past 3.9 years, $100 invested in LFST would have grown to $85, compared to $166 for the S&P 500. That's -3.9% annualized vs 13.8% for the index. LFST has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20